148 related articles for article (PubMed ID: 16029505)
1. Rapid construction of a dendritic cell vaccine through physical perturbation and apoptotic malignant T cell loading.
Salskov-Iversen M; Berger CL; Edelson RL
J Immune Based Ther Vaccines; 2005 Jul; 3():4. PubMed ID: 16029505
[TBL] [Abstract][Full Text] [Related]
2. Improved generation of anti-tumor immunity by antigen dose limitation.
Shofner JD; Vasquez JG; Berger CL; Edelson RL
J Immune Based Ther Vaccines; 2007 Feb; 5():2. PubMed ID: 17291350
[TBL] [Abstract][Full Text] [Related]
3. Development of immunogenic tumor-loaded dendritic cells through physical perturbation and apoptotic cell loading.
Shen X; Berger CL; Tigelaar R; Edelson RL
Immunol Invest; 2008; 37(8):798-821. PubMed ID: 18991097
[TBL] [Abstract][Full Text] [Related]
4. Interaction of cutaneous lymphoma cells with reactive T cells and dendritic cells: implications for dendritic cell-based immunotherapy.
Thumann P; Lüftl M; Moc I; Bagot M; Bensussan A; Schuler G; Jenne L
Br J Dermatol; 2003 Dec; 149(6):1128-42. PubMed ID: 14674889
[TBL] [Abstract][Full Text] [Related]
5. The life cycle of cutaneous T cell lymphoma reveals opportunities for targeted drug therapy.
Berger CL; Edelson R
Curr Cancer Drug Targets; 2004 Nov; 4(7):609-19. PubMed ID: 15578918
[TBL] [Abstract][Full Text] [Related]
6. The growth of cutaneous T-cell lymphoma is stimulated by immature dendritic cells.
Berger CL; Hanlon D; Kanada D; Dhodapkar M; Lombillo V; Wang N; Christensen I; Howe G; Crouch J; El-Fishawy P; Edelson R
Blood; 2002 Apr; 99(8):2929-39. PubMed ID: 11929784
[TBL] [Abstract][Full Text] [Related]
7. Induction of human tumor-loaded dendritic cells.
Berger CL; Xu AL; Hanlon D; Lee C; Schechner J; Glusac E; Christensen I; Snyder E; Holloway V; Tigelaar R; Edelson RL
Int J Cancer; 2001 Feb; 91(4):438-47. PubMed ID: 11251964
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
Edelson RL
Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
[TBL] [Abstract][Full Text] [Related]
9. Replicative response, immunophenotype, and functional activity of monocyte-derived versus CD34(+)-derived dendritic cells following exposure to various expansion and maturational stimuli.
Chen B; Stiff P; Sloan G; Kash J; Manjunath R; Pathasarathy M; Oldenburg D; Foreman KE; Nickoloff BJ
Clin Immunol; 2001 Feb; 98(2):280-92. PubMed ID: 11161986
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells.
Berger CL; Tigelaar R; Cohen J; Mariwalla K; Trinh J; Wang N; Edelson RL
Blood; 2005 Feb; 105(4):1640-7. PubMed ID: 15514008
[TBL] [Abstract][Full Text] [Related]
11. Large-scale immunomagnetic selection of CD14+ monocytes to generate dendritic cells for cancer immunotherapy: a phase I study.
Babatz J; Röllig C; Oelschlägel U; Zhao S; Ehninger G; Schmitz M; Bornhäuser M
J Hematother Stem Cell Res; 2003 Oct; 12(5):515-23. PubMed ID: 14594508
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory dendritic cells generated from nonfractionated bulk peripheral blood mononuclear cell cultures induce growth of cytotoxic T cells against renal cell carcinoma.
Hinkel A; Tso CL; Gitlitz BJ; Neagos N; Schmid I; Paik SH; deKernion J; Figlin R; Belldegrun A
J Immunother; 2000 Jan; 23(1):83-93. PubMed ID: 10687141
[TBL] [Abstract][Full Text] [Related]
13. Transimmunization, a novel approach for tumor immunotherapy.
Berger CL; Hanlon D; Kanada D; Girardi M; Edelson RL
Transfus Apher Sci; 2002 Jun; 26(3):205-16. PubMed ID: 12126207
[TBL] [Abstract][Full Text] [Related]
14. Phenotype and functional analysis of human monocyte-derived dendritic cells loaded with biodegradable poly(lactide-co-glycolide) microspheres for immunotherapy.
Waeckerle-Men Y; Scandella E; Uetz-Von Allmen E; Ludewig B; Gillessen S; Merkle HP; Gander B; Groettrup M
J Immunol Methods; 2004 Apr; 287(1-2):109-24. PubMed ID: 15099760
[TBL] [Abstract][Full Text] [Related]
15. Extracorporeal Photochemotherapy Drives Monocyte-to-Dendritic Cell Maturation to Induce Anticancer Immunity.
Ventura A; Vassall A; Robinson E; Filler R; Hanlon D; Meeth K; Ezaldein H; Girardi M; Sobolev O; Bosenberg MW; Edelson RL
Cancer Res; 2018 Jul; 78(14):4045-4058. PubMed ID: 29764863
[TBL] [Abstract][Full Text] [Related]
16. Generation of dendritic cells from adherent cells of cord blood by culture with granulocyte-macrophage colony-stimulating factor, interleukin-4, and tumor necrosis factor-alpha.
Zheng Z; Takahashi M; Narita M; Toba K; Liu A; Furukawa T; Koike T; Aizawa Y
J Hematother Stem Cell Res; 2000 Aug; 9(4):453-64. PubMed ID: 10982243
[TBL] [Abstract][Full Text] [Related]
17. Efficient presentation of tumor idiotype to autologous T cells by CD83(+) dendritic cells derived from highly purified circulating CD14(+) monocytes in multiple myeloma patients.
Ratta M; Curti A; Fogli M; Pantucci M; Viscomi G; Tazzari P; Fagnoni F; Vescovini R; Sansoni P; Tura S; Lemoli RM
Exp Hematol; 2000 Aug; 28(8):931-40. PubMed ID: 10989194
[TBL] [Abstract][Full Text] [Related]
18. Transimmunization for cutaneous T cell lymphoma: a Phase I study.
Girardi M; Berger CL; Wilson LD; Christensen IR; Thompson KR; Glusac EJ; Edelson RL
Leuk Lymphoma; 2006 Aug; 47(8):1495-503. PubMed ID: 16966259
[TBL] [Abstract][Full Text] [Related]
19. Induction and clonal expansion of tumor-specific cytotoxic T lymphocytes from renal cell carcinoma patients after stimulation with autologous dendritic cells loaded with tumor cells.
Kurokawa T; Oelke M; Mackensen A
Int J Cancer; 2001 Mar; 91(6):749-56. PubMed ID: 11275975
[TBL] [Abstract][Full Text] [Related]
20. [Effects of ovarian carcinoma cells on the maturation and function of human dendritic cells].
Li CD; Zhang WY; Yuan CL; Han LY
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(9):630-4. PubMed ID: 19595165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
